To determine whether increased numbers of activated ECP-expressing eosinophils in the primary melanomas translate into increased numbers of degranulated ECP in the serum and which prognostic impact this has on ICI, a second cohort was examined (Table 3). The gene discussed is RNASE3; the disease is melanoma.